| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |